BiotechTube
Home/Pipeline/Rivela MCED Test

Rivela MCED Test

Multi-Cancer Early Detection

Pre-clinicalActive

Key Facts

Indication
Multi-Cancer Early Detection
Phase
Pre-clinical
Status
Active
Company
EXOSOMICS

About EXOSOMICS

Exosomics is a private, integrated biotechnology company with a core focus on exosome-based diagnostics for early cancer detection. Founded in 2011, it has expanded its business model to include three distinct arms: Rivela Diagnostics for MCED tests, HansaBioMed Life Sciences for EV research tools and services, and a joint venture, LongEVity Bioscience, for beauty applications. The company is positioned at the intersection of the rapidly growing liquid biopsy and EV markets, aiming to translate vesicle biology into clinical and commercial products.

View full company profile

Therapeutic Areas

Oncology

Other Multi-Cancer Early Detection Drugs

DrugCompanyPhase
ALMANAC StudyGuardant HealthResearch
Ausel Cancer TestAusel Cancer InnovationPre-clinical
GAGome for MCEDElyptaClinical Validation
CancerGuard™Exact SciencesPivotal Studies
PATHFINDER 2GRAILInterventional Study
REACH/Galleri-Medicare StudyGRAILProspective Cohort Study
REFLECTION StudyGRAILObservational Study
SUMMIT StudyGRAILObservational Cohort Study
PATHFINDER StudyGRAILInterventional Study
MCED TestMainz BiomedResearch Collaboration